Covid Survey

When it comes to taking the vaccine for COVID-19, readers of The Mountain Advocate seem to be split when asked a simple “yes” or “no” if they would take it.

As of press time, 228 respondents cast their vote through a poll online. Of those, 119 said they will not take a vaccine while 109 said they will.

A few readers on Facebook page commented as to why they couldn’t take the treatment. While many just said “nope,” some comments indicated concerns such as “Not enough research” or “I’m not even happy about the flu shot.” One reader shared concerns that she couldn’t take the vaccine due to her immune system.

The vaccines have shown to be 95% effective and safe to older people, according to Pfizer and Moderna, two of the top three labs developing vaccines for the novel coronavirus.

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, a leading expert and one of President Trump’s original Coronavirus Task Force members, said the results are better than he anticipated. “I’d like to say I would have predicted it, but I would not have,” said Fauci in a statement to

Pfizer says 43,661 people participated in its Phase 3 clinical trial of BNT162b2, the vaccine it has developed to fight the virus. By November 8, 41,135 of the participants had received a second dose of the vaccine.

The results of the vaccine have been highly encouraging, prompting the companies to apply for Emergency Use Authorization with the Food and Drug Administration. To many, the vaccines appear rushed. While the COVID-19 vaccine has been created rather quickly in comparison with vaccines for other diseases, scientists were able to build upon research done on earlier forms of the virus such as SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome) to develop the vaccines for COVID-19, or SARS-COV-2, its scientific name. COVID-19 simply stands for Coronavirus Disease 2019.

Many experts expect the vaccine to be ready for distribution before the end of the year. The Centers for Disease Control has recommended the following groups receive the vaccine first:

Healthcare personnel

Workers in essential and critical industries

People at high risk for severe COVID-19 illness due to underlying medical conditions

People 65 years and older

The vaccine itself will not cost Americans anything out-of-pocket. U.S. taxpayer dollars have been spent to secure millions of doses of the vaccines. The CDC has been working with local governments as well as pharmacies to develop a wide-reaching distribution plan. According to the CDC website, the “CDC is working with pharmacies to offer on-site COVID-19 vaccination services for residents in long-term care settings, including skilled nursing facilities, nursing homes, and assisted living facilities where most individuals are over 65 years of age.”

We need your support

We’ve been there for you, now we’re asking that you be there for us. While we will continue to share COVID-19 and urgent health news for free, we will be requiring a subscription for most of our news and sports content. Please click on SUBSCRIBE or call your local newspaper office.

Charles is a native of Barbourville, Kentucky. He has worked with The Mountain Advocate in various capacities since 2003.

Recommended for you